Recent publications on Biostatistics

Cruz M, Gillen DL, Bender M, Ombao H. Assessing health care interventions via an interrupted time series model: Study power and design considerations. Stat Med. 2019 May 10;38(10):1734-1752. doi: 10.1002/sim.8067. Epub 2019 Jan 7. PubMed

Bender M, Murphy EA, Cruz M, Ombao H. System and unit-level care quality outcomes after reorganizing frontline care delivery to integrate clinical nurse leaders: a quasi-experimental time series study. J Nurs Admin. 2019 49(6), p. 315-322. PubMed

Mosley JD, Feng Q, Wells QS, Van Driest SL, Shaffer CM, Edwards TL, Bastarache L, Wei WQ, Davis LK, McCarty CA, Thompson W, Chute CG, Jarvik GP, Gordon AS, Palmer MR, Crosslin DR, Larson EB, Carrell DS, Kullo IJ, Pacheco JA, Peissig PL, Brilliant MH, Linneman JG, Namjou B, Williams MS, Ritchie MD, Borthwick KM, Verma SS, Karnes JH, Weiss ST, Wang TJ, Stein CM, Denny JC, Roden DM. A study paradigm integrating prospective epidemiologic cohorts and electronic health records to identify disease biomarkers. Nat Commons, 2018 Aug 30;9(1):3522. doi: 10.1038/s41467-018-05624-4. PubMed

Sordillo JE, Switkowski KM, Coull BA, Schwartz J, Kloog I, Gibson H, Litonjua AA, Bobb J, Koutrakis P, Rifas-Shiman SL, Oken E, Gold DR. Relation of prenatal air pollutant and nutritional exposures with biomarkers of allergic disease in adolescence. Sci Rep. 2018 Jul 12;8(1):10578. doi: 10.1038/s41598-018-28216-0. PubMed

Liu SH, Bobb JF, Henn BC, Gennings C, Schnaas L, Tellez-Rojo M, Bellinger D, Arora M, Wright RO, Coull BA. Modeling the health effects of time-varying complex environmental mixtures: mean field variational Bayes for lagged kernel machine regression. Environmetrics, 29 (4).18 May 2018. https://doi.org/10.1002/env.2504. PubMed

Hopp S, Dominici F, Bobb JF. Medical diagnoses of heat wave-related hospital admissions in older adults. Prev Med. 2018 May;110:81-85. doi: 10.1016/j.ypmed.2018.02.001. Epub 2018 Feb 8. PubMed

Chrischilles EA, Gagne JJ, Fireman B, Nelson J, Toh S, Shoaibi A, Reichman ME, Wang S, Nguyen M, Zhang R, Izem R, Goulding MR, Southworth MR, Graham DJ, Fuller C, Katcoff H, Woodworth T, Rogers C, Saliga R, Lin ND, McMahill-Walraven CN, Nair VP, Haynes K, Carnahan RM. Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System. Pharmacoepidemiol Drug Saf. 2018 Jan 10. doi: 10.1002/pds.4375. [Epub ahead of print]. PubMed

Toh S, Wellman R, Coley RY, Horgan C, Sturtevant J, Moyneur E, Janning C, Pardee R, Coleman KJ, Arterburn D, McTigue K, Anau J, Cook AJ. Combining distributed regression and propensity scores: a doubly privacy-protecting analytic method for multicenter research.  Clin Epidemiol. 2018 Nov 27;10:1773-1786. doi: 10.2147/CLEP.S178163. eCollection 2018.  PubMed

Akosile M, Pierce S, Brandt M, Verstovsek S, Borthakur G, Kantarjian H, Ravandi F, Wierda W, Garcia-Manero G, Daver N, Kadia T, Burger JA, Pemmaraju N, Jabbour E, Cortes J. Survival impact of patients (pts) with chronic myeloid leukemia (CML) due to failure from the use of one or more tyrosine kinase inhibitors (TKI). Blood, 126(23), 1587. Accessed December 11, 2017. Retrieved from http://www.bloodjournal.org/content/126/23/1587. PubMed

Soria JC, Adjei AA, Bahleda R, Besse B, Ferte C, Planchard D, Zhou J, Ware J, Morrissey K, Shankar G, Lin W, Schutzman JL, Dy GK, Groen HJM. A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin or pemetrexed and cisplatin in patients with advanced non-small cell lung cancer. Eur J Cancer. 2017 Nov;86:186-196. doi: 10.1016/j.ejca.2017.08.027. Epub 2017 Oct 6. PubMed